William Raoul
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Data on microRNA transcriptomic signatures, predicted gene targets and pathway analysis in response to cetuximab or panitumumab in colorectal cancer cells.
Journal: Data in brief
Published: January 21, 2026
Integrative analysis of circulating biomarkers of colorectal cancer combining mid-infrared spectroscopy and targeted metabolomics.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: December 18, 2025
Evaluation of serum mid-infrared spectroscopy as new prognostic marker for first-line bevacizumab-based chemotherapy in metastatic colorectal cancer.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: February 15, 2024
Delivery of Anticancer Drugs Using Microbubble-Assisted Ultrasound in a 3D Spheroid Model.
Journal: Molecular pharmaceutics
Published: January 04, 2024
Calcium signaling: A therapeutic target to overcome resistance to therapies in cancer.
Journal: Cell calcium
Published: October 11, 2022
Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: January 31, 2022
Panitumumab and cetuximab affect differently miRNA expression in colorectal cancer cells.
Journal: Biomarkers in medicine
Published: June 25, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations.
Journal: Bioanalysis
Published: March 26, 2021
NCLX exchanger: An ambivalent role in colorectal cancer timeline
Journal: Medecine sciences : M/S
Published: February 16, 2021
New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
Journal: Molecules (Basel, Switzerland)
Published: January 07, 2021
Last Updated: 09/26/2026